Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Pharmacol Res. 2023 Feb 10;189:106691. doi: 10.1016/j.phrs.2023.106691

Figure 1.

Figure 1.

Human mast cells release resolvin D1. Resolvin D1 (RvD1) production from preincubated with 20 μM docosahexaenoic acid cord blood-derived mast cells (CBMCs) (A), laboratory of allergic diseases 2 (LAD-2) cells (B), foreskin-derived mast cells (FSMCs) (C) and nasal polyp-derived mast cells (NPMCs) (D) was determined 30 min (30’) or 1h after immunoglobulin E-mediated activation (aIgE) and in non-activated (NA) cells (***p<0.01). Data are expressed as mean ± SEM of three independent experiments.